Description:

VERU Inc., traded under the ticker symbol VERU on the New York Stock Exchange (NYSE), is a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs. The company focuses on areas such as oncology and urology, aiming to provide solutions that can significantly impact patient care. With a robust pipeline of products, VERU continues to expand its presence in the healthcare sector, driven by a commitment to research and development. Investors interested in companies at the forefront of medical innovation may find VERU an attractive option due to its strategic focus and potential growth opportunities.

Data:

Yields: